Institutions · Entity Annotation Prototype (beta)

1articles mentioning institutions

1institution mentions

1distinct institutions extracted

0%of mentions human-reviewed

Active filtersEntity: Henan Cancer Hospital ×

Henan Cancer Hospital

This institution is selected. Its supporting articles are shown below.

Henan Cancer Hospital1

Articles mentioning Henan Cancer Hospital

1 articles · page 1 of 1

Single-arm, open-label, multicentre phase 1b/2 study to evaluate the safety and efficacy of fruquintinib combined with sintilimab and CAPEOX as a first-line treatment for advanced gastric or gastroesophageal junction adenocarcinoma (FUNCTION study): a study protocol

bmjopen · abstract · 2025-09-26 · 1 matching annotations

91.0%

Henan Cancer Hospital Fruquintinib sintilimab CAPEOX oxaliplatin capecitabine chemotherapy immunotherapy

… Guidelines . The study protocol has received approval from the Henan Cancer Hospital ethical committee (Approval No. 2023-237-002). Written informed…

Browse institutions

Henan Cancer Hospital

Articles mentioning Henan Cancer Hospital

Single-arm, open-label, multicentre phase 1b/2 study to evaluate the safety and efficacy of fruquintinib combined with sintilimab and CAPEOX as a first-line treatment for advanced gastric or gastroesophageal junction adenocarcinoma (FUNCTION study): a study protocol